|
||||||
|
 | |
| |
| |
| |
| |
| |
| |
| |
| |
| |
| |
| |
| |
|
Gene: ENSG00000091136 |
Summary for LAMB1 |
 Gene summary |
| Gene information | Ensembl ID | ENSG00000091136 | Gene symbol | LAMB1 |
| Gene name | laminin subunit beta 1 | |
| HGNC | 6486 | |
| Entrez ID | 3912 | |
| Gene type | protein_coding | |
| Synonyms | LAMB1| | |
| UniProtAcc | P07942 |
| Drugs associated with this gene(DrugBank). |
| Gene ID | Gene Symbol | Drug ID | Drug Name | Drug Type |
| ENSG00000091136 | LAMB1 | DB06245 | Lanoteplase | BiotechDrug |
| Cancer therapeutic drugs associated with this gene(NCI). |
| Gene ID | Gene Name | Drug ID | Drug Name | Drug Type | Cancer |
Top |
Structure and expression level for LAMB1 |
| AS events and RNA A-to-I editing events of the gene in TCGA based on Genvode V22 structure. ∗For more information on exon skipping events please check the ExonskipDB database. ∗For more information on exon skipping events please check the CAeditome database. |
 |
| Landscape of gene expressions across multiple cancer types. |
 |
| Differentially expressed gene analysis between tumor male and tumor female samples. |
| Coding Name | Base Mean | log2FoldChange | lfcSE | Stat | P value | P.adjust Value | Cancer Type |
| Differentially expressed gene analysis between tumor male and normal male samples. |
 |
| Coding Name | Base Mean | log2FoldChange | lfcSE | Stat | P value | P.adjust Value | Cancer Type |
| LAMB1 | 9.48e+03 | 1.63e+00 | 3.88e-01 | 4.20e+00 | 2.69e-05 | 1.37e-04 | CHOL |
| Differentially expressed gene analysis between tumor female and normal female samples. |
 |
| Coding Name | Base Mean | log2FoldChange | lfcSE | Stat | P value | P.adjust Value | Cancer Type |
| LAMB1 | 4.09e+03 | 1.02e+00 | 2.52e-01 | 4.04e+00 | 5.44e-05 | 1.86e-04 | LIHC |
Top |
Sex-biased somatic mutation for LAMB1 |
| ∗For more information on exon skipping events please check the ExonskipDB database. |
| Gene ID | Cancer Type | Hugo Symbol | Male | Female | pval | or | ci.up | ci.low | adjPval |
Top |
DNA methylation with beta values for LAMB1 |
| Landscape of DNA methylation across multiple cancer types. |
 |
| Differentially expressed CpG sites between male tumor and female tumor patients. |
| Cancer Type | CpG Site | Position | CpG Island | Position to Gene | ave1 | ave2 | wilcoxon.w | wilcoxon.p | padj | dBeta |
| BRCA | cg02561733 | chr7:108003495 | CGI:chr7:108001350-108003613 | promoter | 3.73e-02 | 1.44e-01 | -2.09e+00 | 3.64e-02 | 4.42e-02 | -1.06e-01 |
| BRCA | cg26087411 | chr7:108003503 | CGI:chr7:108001350-108003613 | promoter | 5.38e-02 | 2.28e-01 | -2.40e+00 | 1.62e-02 | 3.22e-02 | -1.74e-01 |
| BRCA | cg17657268 | chr7:108003511 | CGI:chr7:108001350-108003613 | promoter | 6.11e-02 | 2.05e-01 | -2.24e+00 | 2.50e-02 | 3.81e-02 | -1.44e-01 |
| ACC | cg00471159 | chr7:108001351 | CGI:chr7:108001350-108003613 | promoter,gene body | 3.41e-01 | 4.95e-01 | -2.59e+00 | 9.59e-03 | 2.50e-02 | -1.54e-01 |
| ACC | cg04744624 | chr7:108001325 | CGI:chr7:108001350-108003613 | promoter,gene body | 4.25e-01 | 5.91e-01 | -2.90e+00 | 3.71e-03 | 1.41e-02 | -1.66e-01 |
| Differentially expressed CpG sites between male tumor and male normal patients. |
| Cancer Type | CpG Site | Position | CpG Island | Position to Gene | ave1 | ave2 | wilcoxon.w | wilcoxon.p | padj | dBeta |
| KIRC | cg04744624 | chr7:108001325 | CGI:chr7:108001350-108003613 | promoter,gene body | 3.80e-01 | 2.27e-01 | 3.73e+00 | 1.94e-04 | 3.66e-04 | 1.53e-01 |
| KIRC | cg00471159 | chr7:108001351 | CGI:chr7:108001350-108003613 | promoter,gene body | 3.87e-01 | 1.98e-01 | 3.98e+00 | 6.75e-05 | 1.45e-04 | 1.89e-01 |
| LUSC | cg22338567 | chr7:108001999 | CGI:chr7:108001350-108003613 | UTR,promoter,exon,gene body | 2.51e-01 | 1.41e-02 | 3.87e+00 | 1.08e-04 | 7.20e-04 | 2.37e-01 |
| LUSC | cg06248480 | chr7:108002008 | CGI:chr7:108001350-108003613 | UTR,promoter,exon,gene body | 2.98e-01 | 6.63e-02 | 2.84e+00 | 4.51e-03 | 7.55e-03 | 2.32e-01 |
| LUSC | cg18181496 | chr7:108002094 | CGI:chr7:108001350-108003613 | promoter,gene body | 2.98e-01 | 1.42e-01 | 2.98e+00 | 2.91e-03 | 5.47e-03 | 1.56e-01 |
| BLCA | cg00471159 | chr7:108001351 | CGI:chr7:108001350-108003613 | promoter,gene body | 3.94e-01 | 2.32e-01 | 1.96e+00 | 4.98e-02 | 4.98e-02 | 1.62e-01 |
| BLCA | cg10064162 | chr7:108003804 | CGI:chr7:108001350-108003613 | promoter | 2.57e-01 | 3.81e-01 | -3.15e+00 | 1.65e-03 | 3.38e-03 | -1.23e-01 |
| LIHC | cg00471159 | chr7:108001351 | CGI:chr7:108001350-108003613 | promoter,gene body | 5.37e-01 | 4.32e-01 | 2.77e+00 | 5.64e-03 | 7.34e-03 | 1.06e-01 |
| Differentially expressed CpG sites between female tumor and female normal patients. |
| Cancer Type | CpG Site | Position | CpG Island | Position to Gene | ave1 | ave2 | wilcoxon.w | wilcoxon.p | padj | dBeta |
| BRCA | cg22338567 | chr7:108001999 | CGI:chr7:108001350-108003613 | UTR,promoter,exon,gene body | 1.97e-01 | 2.54e-02 | 8.42e+00 | 3.82e-17 | 1.64e-16 | 1.71e-01 |
| BRCA | cg00471159 | chr7:108001351 | CGI:chr7:108001350-108003613 | promoter,gene body | 6.04e-01 | 5.03e-01 | 5.97e+00 | 2.30e-09 | 5.43e-09 | 1.01e-01 |
| BRCA | cg06248480 | chr7:108002008 | CGI:chr7:108001350-108003613 | UTR,promoter,exon,gene body | 2.53e-01 | 9.80e-02 | 6.44e+00 | 1.23e-10 | 3.20e-10 | 1.55e-01 |
| BRCA | cg18181496 | chr7:108002094 | CGI:chr7:108001350-108003613 | promoter,gene body | 3.31e-01 | 1.46e-01 | 1.04e+01 | 2.44e-25 | 2.14e-24 | 1.85e-01 |
| LUAD | cg00471159 | chr7:108001351 | CGI:chr7:108001350-108003613 | promoter,gene body | 5.51e-01 | 4.07e-01 | 2.92e+00 | 3.48e-03 | 7.46e-03 | 1.44e-01 |
| HNSC | cg00471159 | chr7:108001351 | CGI:chr7:108001350-108003613 | promoter,gene body | 6.17e-01 | 4.69e-01 | 2.65e+00 | 8.13e-03 | 1.67e-02 | 1.48e-01 |
Top |
Exon skipping events with PSI in TCGA for LAMB1 |
| ∗Please access ExonSkipDB for exon skipping annotation. |
| Landscape of exon skipping events across multiple cancer types. |
 |
| Differentially expressed exon skipping events between male tumor and female tumor patients. |
| Cancer Type | Exon Skipping | ave.female_T | ave.female_N | wilcoxon.w | wilcoxon.p | padj | dPSI |
| Differentially expressed exon skipping events between male tumor and male normal patients. |
| Cancer Type | Exon Skipping | ave.female_T | ave.female_N | wilcoxon.w | wilcoxon.p | padj | dPSI |
| Differentially expressed exon skipping events between female tumor and female normal patients. |
| Cancer Type | Exon Skipping | ave.female_T | ave.female_N | wilcoxon.w | wilcoxon.p | padj | dPSI |
Top |
RNA A-to-I editing events in TCGA for LAMB1 |
| ∗Please access CAeditome for RNA editing annotation. |
| Differentially expressed RNA editing events between male tumor and female tumor patients. |
| Cancer Type | Transcript | Editing | ave.male_T | ave.female_T | wilcoxon.w | wilcoxon.p | p_adj | dFre |
| Differentially expressed RNA editing events between male tumor and male normal patients. |
| Cancer Type | Transcript | Editing | ave.male_T | ave.female_T | wilcoxon.w | wilcoxon.p | p_adj | dFre |
| Differentially expressed RNA editing events between female tumor and female normal patients. |
| Cancer Type | Transcript | Editing | ave.male_T | ave.female_T | wilcoxon.w | wilcoxon.p | p_adj | dFre |
| Protein coding RNA editing(s). |
| Editing Position | Variant Type | Gene Symbol | Transcript ID | NTchange | AAchange |
Top |
Sex-biased TF-Gene network for LAMB1 |
| TFs related to LAMB1. ∗The female-biased TF-gene edges were identified if Female_Edge_threshold>0.98 and Male_Edge_threshold<=0.98. ∗The male-biased TF-gene edges were identified if Male_Edge_threshold>0.98 and Female_Edge_threshold<=0.98. |
 |
| Cancer Type | TF | Target Gene | Male Edge Score | Male Edge Threshold | Female Edge Score | Female Edge Threshold | Type |
| DLBC | DMRTA1 | LAMB1 | 2.82e+00 | 3.45e-03 | 3.99e+00 | 9.81e-01 | Female-biased |
| DLBC | FOXO1 | LAMB1 | 3.39e+00 | 8.61e-03 | 4.33e+00 | 9.83e-01 | Female-biased |
| DLBC | NKX3-1 | LAMB1 | 2.94e+00 | 2.02e-03 | 4.27e+00 | 9.88e-01 | Female-biased |
| LAMB1 related gene. ∗Only the gene encode TF might with this result. ∗For more information please check Sex-biased TF-Coding gene network. |
Top |
Sex-biased RBP-ES network for LAMB1 |
| RBPs related to ES in LAMB1. ∗The female-biased RBP-ES edges were identified if Female_Edge_threshold>0.98 and Male_Edge_threshold<=0.98. ∗The male-biased RBP-ES edges were identified if Male_Edge_threshold>0.98 and Female_Edge_threshold<=0.98. |
 |
| Cancer Type | RBP | Target ES | Male Edge Score | Male Edge Threshold | Female Edge Score | Female Edge Threshold | Type |
| THYM | hnRNPK | exon_skip_478937 | 9.15e+00 | 9.88e-01 | 8.81e+00 | 7.65e-03 | Male-biased |
| COAD | EIF4B | exon_skip_478939 | 9.97e+00 | 1.65e-02 | 1.03e+01 | 9.82e-01 | Female-biased |
| DLBC | KHDRBS1 | exon_skip_478930 | 7.21e+00 | 9.80e-01 | 6.84e+00 | 7.05e-03 | Male-biased |
| CHOL | EIF4B | exon_skip_478939 | 1.02e+01 | 8.29e-03 | 1.06e+01 | 9.90e-01 | Female-biased |
| CHOL | SRSF1 | exon_skip_478940 | 9.08e+00 | 9.86e-01 | 8.67e+00 | 9.12e-03 | Male-biased |
| ESCA | BRUNOL6 | exon_skip_478921 | 8.14e+00 | 3.10e-03 | 8.73e+00 | 9.92e-01 | Female-biased |
| ESCA | hnRNPK | exon_skip_478937 | 8.68e+00 | 1.24e-02 | 9.10e+00 | 9.84e-01 | Female-biased |
| READ | EIF4B | exon_skip_478939 | 9.94e+00 | 1.37e-03 | 1.05e+01 | 9.97e-01 | Female-biased |
| READ | hnRNPK | exon_skip_478937 | 8.73e+00 | 5.98e-03 | 9.11e+00 | 9.90e-01 | Female-biased |
| THCA | EIF4B | exon_skip_478939 | 1.05e+01 | 9.97e-01 | 1.00e+01 | 1.72e-03 | Male-biased |
| MESO | BRUNOL6 | exon_skip_478921 | 8.90e+00 | 9.83e-01 | 8.56e+00 | 1.24e-02 | Male-biased |
| MESO | EIF4B | exon_skip_478939 | 1.00e+01 | 1.49e-03 | 1.05e+01 | 9.97e-01 | Female-biased |
| GBM | EIF4B | exon_skip_478939 | 1.00e+01 | 2.33e-03 | 1.05e+01 | 9.96e-01 | Female-biased |
| KIRC | BRUNOL6 | exon_skip_478921 | 8.48e+00 | 1.06e-02 | 8.79e+00 | 9.84e-01 | Female-biased |
| KICH | EIF4B | exon_skip_478939 | 1.04e+01 | 9.90e-01 | 1.01e+01 | 8.29e-03 | Male-biased |
| BLCA | BRUNOL6 | exon_skip_478923 | 8.80e+00 | 9.84e-01 | 8.44e+00 | 1.02e-02 | Male-biased |
| HNSC | EIF4B | exon_skip_478939 | 1.01e+01 | 1.06e-02 | 1.05e+01 | 9.88e-01 | Female-biased |
| LAMB1 related ES. ∗Only the gene encode RBP might with this result. ∗For more information please check Sex-biased RBP-ES network in cancer. |
Top |
Sex-biased CeRNA regulation of gene |
| Sex-biased CeRNA regulation of gene. |
| Gene ID | ceRNA(lncRNA-miRNA-mRNA) | Group | Cancer Type |
Top |
Sex-biased eQTL regulation of gene |
| Sex-biased eQTL regulation of gene (The figures only show the pairs with FDR <1e-5. For more information please check the below table). |
| eQTL | Description |
| Male-specific eQTL regulation. |
| SNP ID | SNP Info | Position to Gene | Effect Score | FDR | Cancer Type | Biased Type |
| rs66556278 | chr7:99290877:A:G | - | 0.267866917176154 | 0.0042955703846611 | GBM | Female-baised eQTL |
| rs144663042 | chr7:99294626:C:T | - | 0.240550440836721 | 0.0184542625693635 | GBM | Female-baised eQTL |
| rs10261635 | chr7:99378863:G:A | - | 0.222213866571128 | 0.0228907958111628 | GBM | Female-baised eQTL |
| rs10236240 | chr7:99379905:A:G | - | 0.222213866571128 | 0.0228907958111628 | GBM | Female-baised eQTL |
| rs10268984 | chr7:99365717:C:T | - | 0.221739359390035 | 0.0242072884001171 | GBM | Female-baised eQTL |
| rs4765 | chr7:99386776:C:T | - | 0.213170188721106 | 0.0433473071971123 | GBM | Female-baised eQTL |
| rs11971640 | chr7:99390430:G:A | - | 0.213170188721106 | 0.0433473071971123 | GBM | Female-baised eQTL |
| rs62479802 | chr7:98170691:A:G | - | 0.132737712544382 | 0.0110897776166187 | LGG | Female-baised eQTL |
| rs62479818 | chr7:98188934:C:G | - | 0.13258667013566 | 0.0112228181356923 | LGG | Female-baised eQTL |
| rs62479765 | chr7:98079051:C:G | - | 0.124547918310604 | 0.0192651152690164 | LGG | Female-baised eQTL |
| rs75563976 | chr7:117354262:C:G | - | 0.0961137063304097 | 0.0211554310638765 | LGG | Female-baised eQTL |
| rs62479799 | chr7:98152632:A:G | - | 0.125267407680994 | 0.0218768721361668 | LGG | Female-baised eQTL |
| rs34343837 | chr7:101635083:G:A | - | 0.118554682971259 | 0.0282266769185381 | BLCA | Female-baised eQTL |
| rs6965163 | chr7:117830639:C:G | - | -0.126451069335061 | 0.0292083491136734 | BLCA | Female-baised eQTL |
| rs2014985 | chr7:98659630:G:A | - | 0.113552114164936 | 0.0199177850818523 | COAD | Female-baised eQTL |
| rs113126106 | chr7:98663051:C:G | - | 0.113226446614461 | 0.0231428609418015 | COAD | Female-baised eQTL |
| rs41268 | chr7:105979119:G:A | - | -0.0701253349747124 | 0.0423861946832591 | COAD | Female-baised eQTL |
| Female-specific eQTL regulation. |
| SNP ID | SNP Info | Position to Gene | Effect Score | FDR | Cancer Type | Biased Type |
| rs10240841 | chr7:113550005:G:A | - | 0.330127832030005 | 0.0398344424893558 | PCPG | Male-baised eQTL |
| rs6949164 | chr7:112252586:C:T | - | 0.118334313272727 | 0.0240381644280372 | GBM | Male-baised eQTL |
| rs4730516 | chr7:112240115:T:A | - | 0.118131694971406 | 0.025341208758979 | GBM | Male-baised eQTL |
| rs4730517 | chr7:112240121:T:A | - | 0.118131694971406 | 0.025341208758979 | GBM | Male-baised eQTL |
| rs3823515 | chr7:112318284:T:A | - | 0.111054072523258 | 0.0356644393977062 | GBM | Male-baised eQTL |
| rs60445595 | chr7:112310711:A:C | - | 0.10788003074946 | 0.0452101902946376 | GBM | Male-baised eQTL |
| rs77574575 | chr7:102975904:C:T | - | 0.0394458033190122 | 0.0492121064272116 | LGG | Male-baised eQTL |
| rs2396570 | chr7:112803486:G:T | - | -0.0518485260737306 | 0.0440904164937897 | KIRC | Male-baised eQTL |
| rs12705034 | chr7:99202349:G:A | - | 0.106171105647081 | 0.00902301067995851 | COAD | Male-baised eQTL |
| rs1404583 | chr7:109164941:A:T | - | -0.128256123060488 | 0.0103302386904641 | COAD | Male-baised eQTL |
| rs79282338 | chr7:109180337:C:A | - | -0.113723558740267 | 0.0254327180084204 | COAD | Male-baised eQTL |
| rs10243061 | chr7:109210912:T:C | - | -0.107997476082713 | 0.0287064847422227 | COAD | Male-baised eQTL |
| rs74606627 | chr7:109211629:A:C | - | -0.107997476082713 | 0.0287064847422227 | COAD | Male-baised eQTL |
| rs28883916 | chr7:109213445:T:G | - | -0.107997476082713 | 0.0287064847422227 | COAD | Male-baised eQTL |
| rs28582559 | chr7:109156938:A:G | - | -0.117769095249599 | 0.0299218356934047 | COAD | Male-baised eQTL |
| rs10231177 | chr7:109158803:G:T | - | -0.117769095249599 | 0.0299218356934047 | COAD | Male-baised eQTL |
| rs10268318 | chr7:109160535:A:G | - | -0.117769095249599 | 0.0299218356934047 | COAD | Male-baised eQTL |
| rs1799052 | chr7:98045889:A:C | - | -0.092646667840313 | 0.0306640335807585 | COAD | Male-baised eQTL |
| rs77970094 | chr7:109196637:G:C | - | -0.112118689237702 | 0.0316721499622078 | COAD | Male-baised eQTL |
| rs10278149 | chr7:109199791:T:C | - | -0.112118689237702 | 0.0316721499622078 | COAD | Male-baised eQTL |
| rs9656154 | chr7:109164560:A:G | - | -0.116360707298482 | 0.0336639952853289 | COAD | Male-baised eQTL |
| rs2030740 | chr7:109207498:T:C | - | -0.111324796914352 | 0.033775095285467 | COAD | Male-baised eQTL |
| rs10236576 | chr7:109230512:A:C | - | -0.112218351949011 | 0.0343346735924427 | COAD | Male-baised eQTL |
| rs7802387 | chr7:109235464:A:G | - | -0.112218351949011 | 0.0343346735924427 | COAD | Male-baised eQTL |
| rs10254806 | chr7:109169713:G:C | - | -0.11398142204855 | 0.0404051407660476 | COAD | Male-baised eQTL |
| rs74665061 | chr7:109174555:C:G | - | -0.111928011322816 | 0.0406045949859106 | COAD | Male-baised eQTL |
| rs10249919 | chr7:109175596:A:G | - | -0.111928011322816 | 0.0406045949859106 | COAD | Male-baised eQTL |
| rs28846699 | chr7:109226182:T:C | - | -0.109222805368994 | 0.0432326718703669 | COAD | Male-baised eQTL |
| rs28850421 | chr7:109225778:A:G | - | -0.108975888966329 | 0.0443373669096124 | COAD | Male-baised eQTL |
| rs76288722 | chr7:109241582:T:C | - | -0.10991070961678 | 0.0446274404210917 | COAD | Male-baised eQTL |
| rs2188435 | chr7:109246223:C:T | - | -0.10991070961678 | 0.0446274404210917 | COAD | Male-baised eQTL |
| rs10232116 | chr7:109153760:C:T | - | -0.112531294018753 | 0.0455013226594882 | COAD | Male-baised eQTL |
| rs847564 | chr7:98053759:T:C | - | -0.0897767174642996 | 0.0459114493960802 | COAD | Male-baised eQTL |
| rs10263638 | chr7:109224747:G:T | - | -0.108458284520036 | 0.0460263765186409 | COAD | Male-baised eQTL |
| rs1405063 | chr7:109615844:C:G | - | 0.0631610675522745 | 0.0488164949456053 | COAD | Male-baised eQTL |
| rs10225255 | chr7:109222412:A:T | - | -0.107518939412311 | 0.0496075475549845 | COAD | Male-baised eQTL |
| rs1525028 | chr7:109219566:T:C | - | -0.107515893792696 | 0.0496169848763248 | COAD | Male-baised eQTL |
| Opposite sex-biased eQTL regulation. |
| SNP ID | SNP Info | Position to Gene | Male Effect | Male FDR | Female Effect | Female FDR | Sex-biased Gene in Cancer | Cancer Type |
Top |
Sex-biased eQTM regulation of gene |
| Sex-biased eQTM regulation of gene (The figures only show the pairs with FDR<1e-5. For more information please check the below table). |
| eQTM | Description |
 | Gene ID: ENSG00000091136 |
| CpG Site: cg00471159 | |
| Position to Gene: gene,promoter | |
| Male Effect: - | |
| Female Effect: -0.145859441975052 | |
 | Gene ID: ENSG00000091136 |
| CpG Site: cg09480446 | |
| Position to Gene: gene | |
| Male Effect: -0.48583374336803 | |
| Female Effect: - | |
 | Gene ID: ENSG00000091136 |
| CpG Site: cg04744624 | |
| Position to Gene: gene,promoter | |
| Male Effect: -0.48583374336803 | |
| Female Effect: - | |
 | Gene ID: ENSG00000091136 |
| CpG Site: cg00471159 | |
| Position to Gene: gene,promoter | |
| Male Effect: -0.48583374336803 | |
| Female Effect: - | |
 | Gene ID: ENSG00000091136 |
| CpG Site: cg09803764 | |
| Position to Gene: gene,exon,CDS | |
| Male Effect: -0.385945829219951 | |
| Female Effect: - | |
 | Gene ID: ENSG00000091136 |
| CpG Site: cg13661703 | |
| Position to Gene: gene | |
| Male Effect: -0.385945829219951 | |
| Female Effect: - |
| Male-specific eQTM regulation. |
| CpG Site | CpG Postion | Position to Gene | Effect Score | FDR | Cor.r | Cor.Pvalue | Cancer Type |
| cg09480446 | chr7:108000490 | gene | -0.48583374336803 | 2.92956859945025e-35 | -0.6642427325558619 | 3.7813870102556686e-38 | LGG |
| cg04744624 | chr7:108001325 | gene,promoter | -0.48583374336803 | 2.92956859945025e-35 | -0.6642427325558619 | 3.7813870102556686e-38 | LGG |
| cg00471159 | chr7:108001351 | gene,promoter | -0.48583374336803 | 2.92956859945025e-35 | -0.6642427325558619 | 3.7813870102556686e-38 | LGG |
| cg09803764 | chr7:107932308 | gene,exon,CDS | -0.385945829219951 | 1.5560711280474e-05 | -0.3037450991230407 | 6.257520869298741e-08 | BLCA |
| cg13661703 | chr7:107995074 | gene | -0.385945829219951 | 1.5560711280474e-05 | -0.3037450991230407 | 6.257520869298741e-08 | BLCA |
| Female-specific eQTM regulation. |
| CpG Site | CpG Postion | Position to Gene | Effect Score | FDR | Cor.r | Cor.Pvalue | Cancer Type |
| cg00471159 | chr7:108001351 | gene,promoter | -0.145859441975052 | 9.77830709688113e-05 | -0.32245094783722134 | 1.4008567970302242e-07 | LUAD |
| Opposite sex-biased eQTM regulation. |
| CpG Site | CpG Postion | CpG Island | Position to Gene | Male Effect | Male FDR | Female Effect | Female FDR | Male Cor | Male P-value | Female Cor | Female P-value | Sex-biased Coding Gene | Cancer Type |
Top |
Sex-biased sQTL regulation of gene |
| Sex-biased sQTL regulation of gene (The figures only show the pairs with FDR <1e-5. For more information please check the below table). |
| sQTL | Description |
| Male-specific sQTL regulation. |
| ES ID | Skipped Exon | ORF Anno | SNP ID | SNP Info | SNP Position to ES | Effect Score | FDR | Cancer Type | Biased Type |
| Female-specific sQTL regulation. |
| ES ID | Skipped Exon | ORF Anno | SNP ID | SNP Info | SNP Position to ES | Effect Score | FDR | Cancer Type | Biased Type |
| Opposite sex-biased sQTL regulation. |
| ES ID | Skipped Exon | ORF Anno | SNP ID | SNP Info | SNP Position to ES | Male Effect | Male FDR | Female Effect | Female FDR | Cancer Type |
Top |
Sex-biased sQTM regulation of gene |
| Sex-biased sQTM regulation of gene (The figures only show the pairs with FDR <1e-5. For more information please check the below table). |
| sQTM | Description |
| Male-specific sQTM regulation. |
| EX ID | Skipped Exon | CPG Site | CPG Position | Position to EX Events | Effect Score | FDR | Cor.r | Cor.Pvalue | ORF_anno | Cancer Type |
| Female-specific sQTM regulation. |
| EX ID | Skipped Exon | CPG Site | CPG Position | Position to EX Events | Effect Score | FDR | Cor.r | Cor.Pvalue | ORF_anno | Cancer Type |
| Opposite sex-biased sQTM regulation. |
| EX ID | EX Info | Skipped Exon | CPG Site | CPG Position | CPG Island | Position to EX Events | Male Effect | Male FDR | Female Effect | Female FDR | Male Correlation | Male P-value | Female Correlation | Female P-value | ORF_anno | Cancer Type |
Top |
Related disease information of LAMB1 |
| Diseases associated with this gene (DisGeNET). |
| Gene ID | Gene Symbol | Disease ID | Disease Name | Number of PMID | Source |
| ENSG00000091136 | LAMB1 | C0004352 | Autistic Disorder | 1 | CTD_human |
| ENSG00000091136 | LAMB1 | C0009324 | Ulcerative Colitis | 1 | CTD_human |
| ENSG00000091136 | LAMB1 | C0009363 | Congenital ocular coloboma (disorder) | 1 | CTD_human |
| ENSG00000091136 | LAMB1 | C0014175 | Endometriosis | 1 | CTD_human |
| ENSG00000091136 | LAMB1 | C0034069 | Pulmonary Fibrosis | 1 | CTD_human |
| ENSG00000091136 | LAMB1 | C0266463 | Lissencephaly | 1 | CTD_human |
| ENSG00000091136 | LAMB1 | C0266483 | Pachygyria | 1 | CTD_human |
| ENSG00000091136 | LAMB1 | C0269102 | Endometrioma | 1 | CTD_human |
| ENSG00000091136 | LAMB1 | C1879312 | Agyria | 1 | CTD_human |
| ENSG00000091136 | LAMB1 | C4554007 | Uveoretinal Coloboma | 1 | CTD_human |
| ENSG00000091136 | LAMB1 | C4721507 | Alveolitis, Fibrosing | 1 | CTD_human |
